Published in Telemedicine Business Week, February 28th, 2007
This trend article about Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "Erythropoietin in clinical practice: current use, effect on survival, and future directions," have been published. "Recombinant human erythropoietin has become an essential part of the management of anemic patients with end-stage renal disease. It is also used to treat the anemia associated with cancer and other diseases, and it improves quality of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.